PTC Therapeutics Phase 2 Data from Spinal Muscular Atrophy Program to be Presented at 20th International Annual Congress of WMS
October 04, 2015 at 18:36 PM EDT
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that clinical data from the company's joint development program with Roche and the ...